Заявка Osmind в YC

Summer 2020Active

Osmind прошел Y Combinator в потоке Summer 2020 как компания из сферы Healthcare. Ниже: чем занимается компания, кто ее основал, и ее заявка в YC, реконструированная вопрос за вопросом в реальной форме YC.

Поток YC: Summer 2020
Сфера: HealthcareHealthcare IT
Размер команды: 55
Статус: Active
Запущено: 2020

Фаундеры

Lucia HuangFounder
Jimmy QianFounder

Чем занимается Osmind

Osmind is the premier platform for clinicians and researchers advancing new life-saving mental health treatments. Today, mental health disorders are one of the leading causes of death worldwide, especially among young adults, and are tied to shortening lifespans. While there have been developments in new psychiatric medications since the first FDA approval in 1954, today there is a growing movement among clinicians, patients, and researchers who are recognizing the need to accelerate new science. The Osmind treatment platform is the first and only solution that solves specific challenges faced by neuropsychiatric clinics, spanning general psychiatry and interventional psychiatry (transcranial magnetic stimulation, ketamine, SPRAVATO®, psychedelic medicine, electroconvulsive therapy). The core electronic health record (EHR) technology is precisely developed for interventional treatment workflows and designed to support a strong therapeutic alliance, including journaling tools and assistance with health plan reimbursement, which is a significant access hurdle for millions of patients. Research from our platform is already helping to set new standards for mental health interventions. For example, in the largest published real-world analysis of ketamine infusion therapy for depression, we teamed up with Stanford University School of Medicine to share findings in the Journal of Affective Disorders (March 2022). We have multiple ongoing research studies leveraging our proprietary real-world data, including an even larger ketamine analysis leveraging machine learning to predict treatment outcomes. Osmind is a San Francisco - based public benefit corporation led by scientists, technologists, and psychiatrists. We are backed by top investors including DFJ Growth, General Catalyst, Future Ventures, Tiger Global, and Y Combinator.

Заявка Osmind в YC, реконструирована

Заявка Y Combinator

Osmind, батч Summer 2020. Реальные вопросы из анкеты, ответы из публичных данных.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Osmind

Describe what your company does in 50 characters or less.

Platform for breakthrough mental health research

What is your company going to make? Please describe your product and what it does or will do.

We built a platform tailored to neuropsychiatric clinics that deliver interventional treatments like ketamine or TMS. Our product handles electronic health records customized for these therapies, supports clinicians with journaling tools, and navigates complicated insurance reimbursement processes. It also collects real-world data for research on mental health treatments.

Where do you live now, and where would the company be based after YC?

We live in San Francisco and would be based there after YC.

Explain your decision regarding location.

San Francisco is where our team and core user base are; it's also where most innovation in healthcare IT and mental health tech happens. Being here keeps us close to partners, clinicians, researchers, and investors.

21 еще ответ в полной заявке

Founders, Progress, Idea, Equity, Curious, Batch Preference находятся в полной версии. Создайте бесплатную учетную запись, чтобы открыть ее в YC Insights, рядом с каждым другим потоком YC.

Смотреть полную заявку

Часто задаваемые вопросы

Это реальная заявка Osmind в YC?

Нет. Y Combinator держит поданные заявки в приватности. Это реконструкция: реальные вопросы формы YC, ответы на которые основаны на публичных данных Osmind (заметки о запуске, бэкграунд фаундеров, описание продукта). Это показывает, как компания вроде Osmind представила бы себя YC, а не текст, который они подали.